[HTML][HTML] Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - Vaccines, 2021 - mdpi.com
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …

Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection.

A Israel, Y Shenhar, I Green, E Merzon… - Vaccines, 2022 - search.ebscohost.com
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …

[PDF][PDF] Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, AA Schäffer, E Ruppin, S Vinker… - eyewideopen.org
Background: Immune protection following either vaccination or infection with SARS-CoV-2
decreases over time. Objective: To determine the kinetics of SARS-CoV-2 IgG antibodies …

[HTML][HTML] Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - Vaccines, 2022 - ncbi.nlm.nih.gov
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …

[PDF][PDF] Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, AA Schäffer, E Ruppin, S Vinker… - pflegefueraufklaerung.de
Background: Immune protection following either vaccination or infection with SARS-CoV-2
decreases over time. Objective: To determine the kinetics of SARS-CoV-2 IgG antibodies …

[PDF][PDF] Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection. Vaccines 2022, 10, 64

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - 2021 - academia.edu
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …

[HTML][HTML] Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - 2021 - europepmc.org
Objective To determine the kinetics of SARS-CoV-2 IgG antibodies following administration
of two doses of BNT162b2 vaccine, or SARS-CoV-2 infection in unvaccinated individuals …

Large‐Scale Study of Antibody Titer Decay Following BNT162b2 mRNA Vaccine or SARS‐CoV‐2 Infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan‐cohen… - Vaccines, 2022 - cris.bgu.ac.il
Immune protection following either vaccination or infection with SARS‐CoV‐2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …

[PDF][PDF] Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, AA Schäffer, E Ruppin, S Vinker - scienceopen.com
Background: Immune protection following either vaccination or infection with SARS-CoV-2
decreases over time. Objective: To determine the kinetics of SARS-CoV-2 IgG antibodies …

Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - Vaccines, 2021 - cir.nii.ac.jp
抄録< jats: p> Immune protection following either vaccination or infection with SARS-CoV-2
is thought to decrease over time. We designed a retrospective study, conducted at Leumit …